Since the dedifferentiation of podocytes plays a key role in the development of different types of glomerulopathies we wondered whether the regulation of Magi2 in the investigated models is a stereotypical consequence of podocyte damage in general or occurs due to podocyte dedifferentiation. The gene discussed is MAGI2; the disease is lipoprotein glomerulopathy.